Drug Profile
Research programme: hydroxypatite-interferon - LTT Bio-Pharma
Alternative Names: HAp-IFNLatest Information Update: 07 Oct 2015
Price :
$50
*
At a glance
- Originator LTT Bio-Pharma
- Class Interferons
- Mechanism of Action Interferon modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 10 May 2010 Early research in Hepatitis C in Japan (unspecified route)